POLYPOIDAL CHOROIDAL VASCULOPATHY
Clinical trials for POLYPOIDAL CHOROIDAL VASCULOPATHY explained in plain language.
Never miss a new study
Get alerted when new POLYPOIDAL CHOROIDAL VASCULOPATHY trials appear
Sign up with your email to follow new studies for POLYPOIDAL CHOROIDAL VASCULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drug trial offers hope for rare vision disorder
Disease control Recruiting nowThis study tests a drug called faricimab, given as an eye injection, in 120 Caucasian patients with polypoidal choroidal vasculopathy (PCV), a condition that causes vision loss. The goal is to see if the treatment improves eyesight and how long the effects last. Participants will…
Matched conditions: POLYPOIDAL CHOROIDAL VASCULOPATHY
Phase: PHASE4 • Sponsor: Association for Innovation and Biomedical Research on Light and Image • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New eye drug regimen could mean fewer shots for PCV patients
Disease control Recruiting nowThis study tests a higher dose of the drug aflibercept (8 mg) given on a personalized schedule to people with a specific eye condition called polypoidal choroidal vasculopathy (PCV), a type of wet macular degeneration. The goal is to see if this approach can safely extend the tim…
Matched conditions: POLYPOIDAL CHOROIDAL VASCULOPATHY
Phase: PHASE3 • Sponsor: Yeungnam University College of Medicine • Aim: Disease control
Last updated May 15, 2026 11:54 UTC